Focuses on issues raised during a workshop on xenotransplantation held by the National Academy of Sciences Institute of Medicine (IOM). Concern over potential infectious disease risks involved in xenotransplantation; Xenotransplantation as a solution to the problem of organ availability; US Food and Drug Administration's actions on clinical trials; Implications for public health.